Cover Image

Analysis of CacyBP / SIP , ERK1 /2, and p38 Expression in Low‐ and High‐Grade Papillary Urothelial Carcinoma

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Natalia Domian, Grzegorz Młynarczyk, Irena Kasacka
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Cancer Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative Analysis of miRNA Expression 106a‐5p and 375‐3p and Proteins ERK1/2, p38, β‐Catenin and E‐Cadherin in Prostate Cancer and Benign Prostatic Hyperplasia
by: Magdalena Smereczańska, et al.
Published: (2025)

Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer
by: Shuo Wang, et al.
Published: (2024)

Distinct Clinicopathological Features of HER2 ‐Negative, HER2 ‐Low, and HER2 ‐Overexpressing Urothelial Carcinoma in a Large Chinese Cohort
by: Shanshan Wang, et al.
Published: (2025)

Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China
by: Siming Li, et al.
Published: (2024)

Treatment‐Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study
by: Amanda Nizam, et al.
Published: (2025)

Real‐Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON‐2 Retrospective Experience
by: Mimma Rizzo, et al.
Published: (2025)

Real‐World Outcomes of Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Results From the Final Analysis of Postmarketing Surveillance
by: Eiji Kikuchi, et al.
Published: (2025)

Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real‐World, Ambispective RAVE‐Bladder Study
by: Ilya Tsimafeyeu, et al.
Published: (2025)

The Prognosis of Urothelial Carcinoma Between Kidney Transplantation Recipients and Normal Patients: A Propensity Score‐Matched Study
by: Wu Taihao, et al.
Published: (2025)

Exploring the Potential of Enhanced Prognostic Performance of NCCN‐IPI in Diffuse Large B‐Cell Lymphoma by Integrating Tumor Microenvironment Markers: Stromal FOXC1 and Tumor pERK1/2 Expression
by: Ji‐Ye Kim, et al.
Published: (2024)

Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas
by: William A. Ziaziaris, et al.
Published: (2024)

A Novel Urine DNA Predictor for Noninvasive Early Diagnosis and Monitoring Minimal Residual Disease of Upper Tract Urothelial Carcinoma
by: Wei Zuo, et al.
Published: (2024)

Clinical Effectiveness of Tislelizumab With Gemcitabine/Cisplatin Versus Gemcitabine/Cisplatin Alone as Adjuvant Therapy for High‐Risk Muscle‐Invasive Urothelial Carcinoma: A Real‐World Study
by: Yanjun Wang, et al.
Published: (2025)

CacyBP/SIP Protein Regulates the Length and Branching of Neuronal Processes During Cortical Development
by: Katarzyna Bartkowska, et al.
Published: (2025)

RETRACTION : LncRNA CCAT2 Promotes the Proliferation and Metastasis of Colorectal Cancer Through Activation of the ERK and Wnt Signaling Pathways by Regulating GNB2 Expression
Published: (2025)

Mass Spectrometry‐Driven Proteomic Biomarkers for Serum‐Based Detection of Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm‐Associated Invasive Carcinoma
by: HyunGyo Jung, et al.
Published: (2026)

A Phase I/IB, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced Prostate, Renal or Urothelial Carcinoma
by: Roberto Pili, et al.
Published: (2025)

Integrative Single‐Cell and Machine Learning Analysis Identifies an EMT ‐Associated Prognostic Signature for Papillary Thyroid Cancer
by: Tianfeng Xu, et al.
Published: (2026)

Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Subgroup Analyses of Post‐Marketing Surveillance Data by Age, Prior Chemotherapy Regimen, and Best Overall Response to Prior Chemotherapy
by: Masayoshi Nagata, et al.
Published: (2025)

Stanniocalcin 2‐Induced Autophagy Confers Resistance of Lung Cancer Cells to EGFR Inhibition via the ERK /Beclin 1 Signaling
by: Yi‐Nan Liu, et al.
Published: (2026)

Imaging‐Based Prediction of Ki‐67 Expression in Hepatocellular Carcinoma: A Retrospective Study
by: Chiyu Cai, et al.
Published: (2025)

High expression of SLC7A1 in high‐grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT
by: Shijing You, et al.
Published: (2024)

Risk Factor and Prediction Model for Malignant Transformation in Pancreatic Intraductal Papillary Mucinous Neoplasm
by: Dujiang Yang, et al.
Published: (2025)

Kupffer Phase Radiomics Signature in Sonazoid Contrast‐Enhanced Ultrasound Predicts Immunohistochemistry Marker Expression in Hepatocellular Carcinoma
by: Chen Li, et al.
Published: (2025)

The Role of Chemokine (C‐C Motif) Ligand 7 (CCL7) in Hepatocellular Carcinoma: Expression, Function, and Mechanisms
by: Yangkun Luo, et al.
Published: (2025)

Immunohistochemical Analysis of Potential Therapeutic Targets PRAME , FOLR1 , and CLDN18.2 in Salivary Gland Carcinomas
by: Lukas A. Brust, et al.
Published: (2026)

Treatment Patterns and Radical Cystectomy Outcomes in Patients Diagnosed With Urothelial Nonmetastatic Muscle‐Invasive Bladder Cancer in the United States
by: Bernard Bright Davies‐Teye, et al.
Published: (2025)

Bi‐Regional Machine Learning Radiomics Based on CT Noninvasively Predicts LOX Expression Level and Overall Survival in Hepatocellular Carcinoma
by: Kexin Gao, et al.
Published: (2025)

RETRACTED: LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expression
by: Jinhai Tian, et al.
Published: (2024)

Analysis of Candidate miRNAs ' Expression in Pancreatic Cancer
by: Rabeah Al‐Temaimi, et al.
Published: (2024)

Navigating Life With High‐Grade Glioma: Experiences and Needs of Adolescents and Young Adults
by: Kaviya Devaraja, et al.
Published: (2025)

Systematic Review and Meta‐Analysis: Taurine and Its Association With Colorectal Carcinoma
by: Akshat Sinha, et al.
Published: (2024)

Glucagon‐Like Peptide‐1 Receptor Agonists and Hepatocellular Carcinoma Prevention: A Meta‐Analysis and Clinical Decision Framework
by: Andrea Dalbeni, et al.
Published: (2025)

A Retrospective Study on the Clinicopathological Characteristics and Prognostic Analysis of Gynecologic Neuroendocrine Carcinoma
by: Yedan Ren, et al.
Published: (2025)

Paranasal Sinus Squamous Cell Carcinoma and Adenocarcinoma: A SEER Database Analysis
by: Lacy Brame, et al.
Published: (2026)

Association Between Nasopharyngeal Carcinoma and Chinese Medicine Constitution: A Meta‐Analysis
by: Shun‐Qi Chen, et al.
Published: (2026)

Transcriptome Concordance Between Borderline Tumors and Endometrioid Carcinoma: An Integrative Genomic Analysis
by: Mio Takahashi, et al.
Published: (2025)

Factor Structures of the Hospital Anxiety and Depression Scale in Cancer: Implications of Comprehensive Confirmatory Analysis on the German Version of the HADS in an Oncological Sample
by: Thilo Dietz, et al.
Published: (2026)

The Treatment of Primary Lymphoepithelioma‐Like Carcinoma in the Head and Neck and Nasopharyngeal Carcinoma
by: Qiaohong Lin, et al.
Published: (2024)

RIOK1: A Novel Oncogenic Driver in Hepatocellular Carcinoma
by: Chunyan Ruan, et al.
Published: (2025)